Home>Topics>Companies>Eli Lilly

Eli Lilly LLY

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. Lilly to test combinations with Merck, Bristol-Myers' cancer drugs

      Headlines

      Tue, 13 Jan 2015

      Jan 13 (Reuters) - Eli Lilly & Co signed two separate deals with Merck & Co Inc and Bristol-Myers Squibb Co to test combinations of its cancer treatments with two recently approved therapies that belong to a promising new class of drugs.

    2. UPDATE 2-Lilly forecasts 2015 earnings, revenue shy of Street estimates

      Headlines

      Wed, 7 Jan 2015

      Jan 7 (Reuters) - Eli Lilly and Co forecast 2015 earnings and revenue just shy of market expectations as the drugmaker looks to bounce back after the expiration of patents on some of its biggest...

    3. Lilly 2015 revenue forecast falls short of Wall St estimates

      Headlines

      Wed, 7 Jan 2015

      Jan 7 (Reuters) - Eli Lilly and Co, which has been battered in the past three years by competition from generics, forecast 2015 revenue shy of Wall Street expectations.

    4. Lilly Issues Strong Long-Term Cost Control Guidance, Leading to Fair Value Increase

      Commentary

      Wed, 7 Jan 2015

      Eli Lilly issued 2015 and long-term guidance than ran slightly above our expectations on stronger cost controls, leading us to increase

    5. Nominees for 2014 Domestic-Stock Fund Manager of the Year

      Headlines

      Mon, 5 Jan 2015

      off in a big way in 2014. Notably, big biotech and pharmaceutical holdings--such as Biogen Idec BIIB, Amgen AMGN, Eli Lilly LLY, Roche, and Novartis NVS--in all six funds posted strong returns for the second-straight year. Managers Fried

    6. BRIEF-Virbac closes Sentinel brands family acquisition Eli Lilly

      Headlines

      Mon, 5 Jan 2015

      * Announces closing of Sentinel brands family acquisition in United States from Eli Lilly

    7. Lilly must divest Sentinel products after FTC nod on Novartis deal

      Headlines

      Mon, 22 Dec 2014

      WASHINGTON (Reuters) - Eli Lilly and Co has won approval to buy Novartis AG's animal health unit on condition that it divests its Sentinel line of products for treating heartworm in dogs, the Federal...

    8. Lilly to divest some Sentinel products to win approval on Novartis

      Headlines

      Mon, 22 Dec 2014

      WASHINGTON, Dec 22 (Reuters) - Eli Lilly and Co has won approval to buy Novartis AG's animal health unit on condition that it divest the Sentinel line of products for treating heartworm in dogs, the...

    9. UPDATE 1- Eli Lilly and Adocia agree to develop fast-acting insulin

      Headlines

      Fri, 19 Dec 2014

      PARIS, Dec 19 (Reuters) - U.S. drugmaker Eli Lilly and French biotech Adocia said on Friday they agreed a worldwide licensing partnership to develop an ultra-rapid insulin to treat patients with Type...

    10. Eli Lilly and Adocia agree to develop ultra-rapid insulin

      Headlines

      Fri, 19 Dec 2014

      PARIS, Dec 19 (Reuters) - U.S. drugmaker Eli Lilly and French biotech Adocia said on Friday they agreed a worldwide licensing partnership to develop ultra-rapid insulin to treat patients with Type 1...

    « Prev12345Next »
    Content Partners